Oral administration of quercetin and fisetin potentiates photocarcinogenesis in UVR-exposed hairless mice

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Oral administration of quercetin and fisetin potentiates photocarcinogenesis in UVR-exposed hairless mice. / Pihl, Celina; Granborg, Jonatan Riber; Pinto, Fernanda Endringer; Bjerring, Peter; Andersen, Flemming; Janfelt, Christian; Haedersdal, Merete; Lerche, Catharina Margrethe.

In: Phytomedicine Plus, Vol. 4, No. 2, 100547, 2024.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Pihl, C, Granborg, JR, Pinto, FE, Bjerring, P, Andersen, F, Janfelt, C, Haedersdal, M & Lerche, CM 2024, 'Oral administration of quercetin and fisetin potentiates photocarcinogenesis in UVR-exposed hairless mice', Phytomedicine Plus, vol. 4, no. 2, 100547. https://doi.org/10.1016/j.phyplu.2024.100547

APA

Pihl, C., Granborg, J. R., Pinto, F. E., Bjerring, P., Andersen, F., Janfelt, C., Haedersdal, M., & Lerche, C. M. (2024). Oral administration of quercetin and fisetin potentiates photocarcinogenesis in UVR-exposed hairless mice. Phytomedicine Plus, 4(2), [100547]. https://doi.org/10.1016/j.phyplu.2024.100547

Vancouver

Pihl C, Granborg JR, Pinto FE, Bjerring P, Andersen F, Janfelt C et al. Oral administration of quercetin and fisetin potentiates photocarcinogenesis in UVR-exposed hairless mice. Phytomedicine Plus. 2024;4(2). 100547. https://doi.org/10.1016/j.phyplu.2024.100547

Author

Pihl, Celina ; Granborg, Jonatan Riber ; Pinto, Fernanda Endringer ; Bjerring, Peter ; Andersen, Flemming ; Janfelt, Christian ; Haedersdal, Merete ; Lerche, Catharina Margrethe. / Oral administration of quercetin and fisetin potentiates photocarcinogenesis in UVR-exposed hairless mice. In: Phytomedicine Plus. 2024 ; Vol. 4, No. 2.

Bibtex

@article{b97a0e5c3c114c67b461fb9dd40f9ac1,
title = "Oral administration of quercetin and fisetin potentiates photocarcinogenesis in UVR-exposed hairless mice",
abstract = "Background: Phytochemicals have demonstrated great potential as photoprotectants. Apple-derived compounds such as quercetin, fisetin, and rutin are reported to provide topical photoprotection, but oral delivery has not been explored. Purpose: To determine the photoprotective effects of oral administration of quercetin, fisetin, and rutin, and their accumulation in skin assessed through mass spectrometry imaging. Study design: Groups of 25 hairless mice (n = 125 mice) received in the daily feed 100 mg/kg quercetin, fisetin, or rutin, 600 mg/kg nicotinamide in water as a positive control, or no supplementation as the UV control. The animals were exposed to ultraviolet radiation (UVR) equivalent to 3.5 standard erythema doses thrice weekly. Method: Mass spectroemetry imaging was used to assess local skin accumulation. Results: Oral administration of quercetin and fisetin reduced the time to tumour onset (Quercetin: second and third tumour [p < 0.045]; fisetin: third tumour [p < 0.021]), with no observed effect for rutin. Nicotinamide delayed the onset of all three recorded tumours (p < 0.0082). Results were supported by accelerated tumour growth following quercetin treatment (p < 0.0069), whereas nicotinamide reduced tumour growth (p < 0.00015). Skin accumulation of the compounds could not be demonstrated, suggesting other mechanisms must be explored to explain these effects on UVR-induced carcinogenesis. Conclusion: Oral administration of quercetin and fisetin to hairless mice increased UVR-induced tumour development. These results indicate a need for caution when selecting candidates for photoprotectants.",
keywords = "Hairless mice, Oral delivery, Photoprotection, Phytochemicals, Skin cancer, Ultraviolet radiation",
author = "Celina Pihl and Granborg, {Jonatan Riber} and Pinto, {Fernanda Endringer} and Peter Bjerring and Flemming Andersen and Christian Janfelt and Merete Haedersdal and Lerche, {Catharina Margrethe}",
note = "Publisher Copyright: {\textcopyright} 2024",
year = "2024",
doi = "10.1016/j.phyplu.2024.100547",
language = "English",
volume = "4",
journal = "Phytomedicine Plus",
issn = "2667-0313",
publisher = "Elsevier",
number = "2",

}

RIS

TY - JOUR

T1 - Oral administration of quercetin and fisetin potentiates photocarcinogenesis in UVR-exposed hairless mice

AU - Pihl, Celina

AU - Granborg, Jonatan Riber

AU - Pinto, Fernanda Endringer

AU - Bjerring, Peter

AU - Andersen, Flemming

AU - Janfelt, Christian

AU - Haedersdal, Merete

AU - Lerche, Catharina Margrethe

N1 - Publisher Copyright: © 2024

PY - 2024

Y1 - 2024

N2 - Background: Phytochemicals have demonstrated great potential as photoprotectants. Apple-derived compounds such as quercetin, fisetin, and rutin are reported to provide topical photoprotection, but oral delivery has not been explored. Purpose: To determine the photoprotective effects of oral administration of quercetin, fisetin, and rutin, and their accumulation in skin assessed through mass spectrometry imaging. Study design: Groups of 25 hairless mice (n = 125 mice) received in the daily feed 100 mg/kg quercetin, fisetin, or rutin, 600 mg/kg nicotinamide in water as a positive control, or no supplementation as the UV control. The animals were exposed to ultraviolet radiation (UVR) equivalent to 3.5 standard erythema doses thrice weekly. Method: Mass spectroemetry imaging was used to assess local skin accumulation. Results: Oral administration of quercetin and fisetin reduced the time to tumour onset (Quercetin: second and third tumour [p < 0.045]; fisetin: third tumour [p < 0.021]), with no observed effect for rutin. Nicotinamide delayed the onset of all three recorded tumours (p < 0.0082). Results were supported by accelerated tumour growth following quercetin treatment (p < 0.0069), whereas nicotinamide reduced tumour growth (p < 0.00015). Skin accumulation of the compounds could not be demonstrated, suggesting other mechanisms must be explored to explain these effects on UVR-induced carcinogenesis. Conclusion: Oral administration of quercetin and fisetin to hairless mice increased UVR-induced tumour development. These results indicate a need for caution when selecting candidates for photoprotectants.

AB - Background: Phytochemicals have demonstrated great potential as photoprotectants. Apple-derived compounds such as quercetin, fisetin, and rutin are reported to provide topical photoprotection, but oral delivery has not been explored. Purpose: To determine the photoprotective effects of oral administration of quercetin, fisetin, and rutin, and their accumulation in skin assessed through mass spectrometry imaging. Study design: Groups of 25 hairless mice (n = 125 mice) received in the daily feed 100 mg/kg quercetin, fisetin, or rutin, 600 mg/kg nicotinamide in water as a positive control, or no supplementation as the UV control. The animals were exposed to ultraviolet radiation (UVR) equivalent to 3.5 standard erythema doses thrice weekly. Method: Mass spectroemetry imaging was used to assess local skin accumulation. Results: Oral administration of quercetin and fisetin reduced the time to tumour onset (Quercetin: second and third tumour [p < 0.045]; fisetin: third tumour [p < 0.021]), with no observed effect for rutin. Nicotinamide delayed the onset of all three recorded tumours (p < 0.0082). Results were supported by accelerated tumour growth following quercetin treatment (p < 0.0069), whereas nicotinamide reduced tumour growth (p < 0.00015). Skin accumulation of the compounds could not be demonstrated, suggesting other mechanisms must be explored to explain these effects on UVR-induced carcinogenesis. Conclusion: Oral administration of quercetin and fisetin to hairless mice increased UVR-induced tumour development. These results indicate a need for caution when selecting candidates for photoprotectants.

KW - Hairless mice

KW - Oral delivery

KW - Photoprotection

KW - Phytochemicals

KW - Skin cancer

KW - Ultraviolet radiation

U2 - 10.1016/j.phyplu.2024.100547

DO - 10.1016/j.phyplu.2024.100547

M3 - Journal article

AN - SCOPUS:85188704822

VL - 4

JO - Phytomedicine Plus

JF - Phytomedicine Plus

SN - 2667-0313

IS - 2

M1 - 100547

ER -

ID: 387226439